arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Ardent Health, Inc.

ARDT

$10.64 ▼ -0.29 (-2.70%) at close

14 Visible periods

26 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Neutral

auto_awesome

Analytical Summary

Ardent Health, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.5B

Dividend Yield —

Revenue Growth -1.4% ↘

Op. Margin —

ROIC —

FCF / Share $1.39 ↗

Trailing P/E 88.7x

Price / Book 1.1x

FCF Yield 13.1%

Debt / Equity 0.79

info Valuation on last close. End-of-day price, Sep 23, 2026.

14-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.62B

↓ -1.4% —

Net Income Profit after all expenses

$39.85M

↓ -3.7% —

FCF / Share Free cash flow per share

$1.39

↑ +425.7% —

Long-Term Debt Long-term obligations

$1.07B

— 0.0% —

Health Breakdown

Profitability ↓

Returns ↑

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue Growth YoY (%)	-1.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-118%)	7.0% Fair → Fair Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-13%)	-0.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-101%)	8.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9%)	11.9% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+48%)	4.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-49%)	19.3% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+142%)	5.2% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-35%)	7.5% Fair Fair Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-7%)	—	—	—	—	—
EPS Growth YoY (%)	-76.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-63.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	52.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	11.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	30.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	-3.7% Weak → Weak Stable Year-over-year change in net income	-3.7% Weak ↓ Weak Declining Year-over-year change in net income	-60.6% Weak ↓ Weak Declining Year-over-year change in net income	53.0% Excellent → Excellent Stable Year-over-year change in net income	53.0% Excellent ↓ Excellent Declining Year-over-year change in net income	53.0% Excellent ↓ Excellent Declining Year-over-year change in net income	N/M	552.8% Excellent Excellent Year-over-year change in net income	552.8% Excellent Excellent Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-140.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-51.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	5.8% Fair Fair Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	-22.7% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Effective Tax Rate (%) (%)	19.7% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.6% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.6% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	154.8% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	21.6% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.5% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.8% Good ↓ Good Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.4% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.5% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	18.9% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-22.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	15.8% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	17.9% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	2.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-80%)	2.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	2.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-77%)	2.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-78%)	2.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-79%)	2.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-77%)	7.1% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-41%)	1.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-84%)	1.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	1.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-84%)	-0.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-103%)	0.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-97%)	0.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-97%)	—
FCF Margin (%) (%)	12.1% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	-3.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	13.9% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	9.8% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-1.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	7.4% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-1.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	5.0% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	6.4% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	4.94x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	4.97x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	3.73x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	-0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-16.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	21.40x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Common Equity (%) (%)	3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-80%)	3.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-80%)	3.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	3.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-78%)	3.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	10.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-33%)	2.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	3.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	—	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Debt to Equity (x)	0.79x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+32%)	0.80x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+34%)	0.87x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+44%)	0.91x Fair → Fair Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+51%)	0.90x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+50%)	0.96x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+60%)	0.96x Fair ↓ Fair Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+60%)	1.08x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+80%)	1.46x Caution Caution Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+144%)	—	—	—	—	—
Net Debt (USD)	$348.73M	$463.07M	$406.36M	$514.46M	$585.66M	$631.06M	$529.03M	$520.58M	$747.42M	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$11.45	$11.34	—	$11.16	$11.72	$10.69	—	$10.57	$11.66	$11.41	—	$10.92	$10.85	—
Basic EPS, GAAP (USD)	$0.12	$0.28	$0.31	$-0.17	$0.52	$0.30	$0.85	$0.19	$0.34	$0.21	$-0.03	$0.17	$0.26	—
Free Cash Flow per Share (USD)	$1.39	$-0.43	—	$1.09	—	$-0.18	—	—	—	$-0.12	—	$0.70	—	—
Book Value per Share (USD)	$9.52	$9.34	$9.01	$8.65	$8.77	$8.22	$7.93	$7.34	$1.52	—	—	—	—	—
Tangible Book Value per Share (USD)	$3.32	$3.20	$2.86	$2.52	$2.63	$2.09	$1.96	$1.12	$-0.23	—	—	—	—	—
Basic Weighted Avg Shares (shares)	141.69M	141.27M	—	141.23M	140.37M	140.06M	—	137.11M	126.12M	126.12M	—	126.12M	126.12M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$1.08B	$1.07B	$1.01B	$1.01B	$996.24M	$931.12M	$887.33M	$803.36M	$592.75M	—	—	—	—	—
LT Debt (USD)	$1.07B	$1.07B	$1.12B	$1.12B	$1.13B	$1.13B	$1.09B	$1.08B	$1.08B	—	—	—	—	—
Total Equity (USD)	$1.35B	$1.34B	$1.29B	$1.24B	$1.25B	$1.18B	$1.13B	$1.01B	$739.90M	—	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$1.62B	$1.60B	$1.61B	$1.58B	$1.65B	$1.50B	$1.61B	$1.45B	$1.47B	$1.44B	$1.35B	$1.38B	$1.37B	—
Depreciation Expense (USD)	$41.34M	$42.99M	$41.04M	$39.16M	—	$36.20M	$37.85M	—	—	$35.35M	$35.98M	$35.49M	—	—
Net Income, GAAP (USD)	$39.85M	$39.85M	$44.96M	$41.38M	$41.38M	$41.38M	$114.20M	$27.05M	$27.05M	$27.05M	$-4.15M	$4.14M	$4.14M	—
Operating Cash Flow (USD)	$196.74M	$-60.22M	$223.44M	$154.37M	—	$-24.79M	$119.57M	—	—	$-14.69M	$67.50M	$88.65M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 2 days ago 4 years · 14 quarters

Ardent Health, Inc.

Analytical Summary

14-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare ARDT with peers